Stay updated on AK104 Dual Checkpoint Blockade in T-cell Lymphoma Clinical Trial
Sign up to get notified when there's something new on the AK104 Dual Checkpoint Blockade in T-cell Lymphoma Clinical Trial page.

Latest updates to the AK104 Dual Checkpoint Blockade in T-cell Lymphoma Clinical Trial page
- Check3 days agoChange DetectedA notice says NIH websites are transitioning terminology from “Artificial Intelligence” to “Super Intelligence” under Executive Order 14434, and directs visitors to updates and FAQs.SummaryDifference0.9%

- Check10 days agoChange DetectedThe website footer now identifies the site as revision v3.7.2 instead of v3.7.1.SummaryDifference0.1%

- Check17 days agoChange DetectedThe site footer revision number changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check37 days agoChange DetectedThe study record history now shows revision 3.7.0 as the latest entry, replacing the previous 3.6.6. This change records an updated version of the study record in the history.SummaryDifference0.1%

- Check59 days agoChange DetectedThe study record history now shows a new version (v3.6.6) replacing the previous v3.6.5, indicating an administrative update to the page.SummaryDifference0.1%

- Check80 days agoChange DetectedA new revision entry v3.6.5 has been added to the study record history, and the previous revision v3.6.4 has been removed.SummaryDifference0.1%

Stay in the know with updates to AK104 Dual Checkpoint Blockade in T-cell Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AK104 Dual Checkpoint Blockade in T-cell Lymphoma Clinical Trial page.